725 filings
Page 3 of 37
8-K
pnwxz6h9
10 Aug 23
Aptose Reports Results for the Second Quarter 2023
4:10pm
424B3
qsenhv2t dq1bcgj0nr6
6 Jul 23
Prospectus supplement
4:01pm
EFFECT
y6e4obj tms
3 Jul 23
Notice of effectiveness
12:15am
S-1/A
l86n zwd7x
28 Jun 23
IPO registration (amended)
4:15pm
CORRESP
379sp
28 Jun 23
Correspondence with SEC
12:00am
8-K
riltd abeewr9al
26 Jun 23
Regulation FD Disclosure
4:10pm
UPLOAD
jyo8catt6 e3hvr
26 Jun 23
Letter from SEC
12:00am
S-1
drnvdgswf dzvjitk
16 Jun 23
IPO registration
6:42pm
8-K
2qwglbo s2h9rh
12 Jun 23
Aptose Presents Highlights from Clinical Update
6:05am
8-K
3o9ejkd60fyu fx7tzr
5 Jun 23
Aptose Biosciences Provides Update on Reverse Stock Split
7:40am
8-K
troohwi
31 May 23
Regulation FD Disclosure
7:30am
8-K
he2bw8h64tcj
26 May 23
Entry into a Material Definitive Agreement
4:01pm
8-K
3yvikik ngjz8pwmgx6
23 May 23
Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders
5:30pm
8-K
174 qk8ipjgpbge6
8 May 23
Aptose Reports Results for the First Quarter 2023
4:05pm
424B5
3rng4z whla4g
3 Apr 23
Prospectus supplement for primary offering
4:22pm